TransMedics Group, Inc. is a commercial-stage medical technology company. The Company is focused on developing organ transplant therapy for end-stage organ failure patients across multiple disease states. The Company has designed and developed an organ care system (OCS), a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It designed its OCS technology platform to perfuse donor organs with warm, oxygenated, nutrient-enriched blood, while maintaining the organs in a living, functioning state. It has developed three OCS products, one each for lung, heart and liver transplantation. Its products include OCS Lung, OCS Heart, and OCS Liver. Its OCS product consists of three components customized for each organ, which include the OCS Console, OCS Perfusion Set and OCS Solutions. It is also developing OCS products for additional organs, including kidneys.
Summary Pivot reset about 10 days ago, which is what I was originally watching for. Pivot BO again, but on little volume. Made a weak move up to turn then BO there on little volume. Turn BO failed on increasing volume and retested 50-day. Retest…
Technicals Today closed back under the turn. It happened a lot quicker than I thought it would. I see the odds in favor of continued market pullback. Therefore, I'm thinking a complete pivot reset is the more likely outcome than just a retest. With that…
Base Count I actually just sold this one in anticipation of a market correction. It still may, but I should have held this a little longer. Last week it made a nice break out of the Base 1 Cup & Handel. Keep on watch for…